Agrawal Arpana, Bierut Laura J
Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri.
Alcohol Res. 2012;34(3):274-81.
Researchers are using various strategies to identify the genes that may be associated with alcoholism. The initial efforts primarily relied on candidate gene and linkage studies; more recently, however, modern advances in genotyping have resulted in widespread use of genome-wide association studies for alcohol dependence. The key findings of the earlier studies were that variations (i.e., polymorphisms) in the DNA sequences of the genes encoding alcohol dehydrogenase 1B (i.e., the ADH1B gene), aldehyde dehydrogenase 2 (i.e., the ALDH2 gene), and other alcohol-metabolizing enzymes mediate the risk for alcoholism; moreover, these polymorphisms also have an impact on the risk of alcohol-related cancers, such as esophageal cancer. In addition, a gene encoding one of the receptors for the neurotransmitter γ-aminobutyric acid (GABA) known as GABRA2 seems to have a role in the development of alcohol dependence. Genome-wide association studies now offer a host of emerging opportunities, as well as challenges, for discovering the genetic etiology of alcohol dependence and for unveiling new treatment strategies.
研究人员正在运用各种策略来识别可能与酒精成瘾相关的基因。最初的研究主要依赖候选基因和连锁研究;然而,最近基因分型技术的现代进展使得全基因组关联研究在酒精依赖研究中得到广泛应用。早期研究的主要发现是,编码乙醇脱氢酶1B(即ADH1B基因)、乙醛脱氢酶2(即ALDH2基因)和其他酒精代谢酶的基因DNA序列变异(即多态性)介导了酒精成瘾的风险;此外,这些多态性还对酒精相关癌症(如食管癌)的风险产生影响。此外,一种编码神经递质γ-氨基丁酸(GABA)受体之一的基因GABRA2似乎在酒精依赖的发展中起作用。全基因组关联研究现在为发现酒精依赖的遗传病因和揭示新的治疗策略提供了大量新机会以及挑战。